Acceleron Pharma Inc Revenue per Employee (XLRN), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Acceleron Pharma inc  (NASDAQ: XLRN)
 

Acceleron Pharma Inc's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 51.58% in the third quarter 2021, year on year to cumulative value of $113 million, Acceleron Pharma Inc's revenue per employee grew on a trailing twelve months basis to $ 250,584, this is below the company average.
Within the Healthcare sector Employees of 209 other companies have achieved higher revenue per employee. While Acceleron Pharma Inc's total ranking has deteriorated compared to the previous quarter from 0 to 2079. Acceleron Pharma Inc has 450 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

XLRN Revenue per Employee (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter		 (Sep 30 2020)
III. Quarter
Y / Y Revenue Change 51.58 % -29.71 % 469.94 % -34.25 % 436.15 %
Sales per Employee (TTM) $ 250,584 224,722 250,971 205,607 235,547
XLRN's Total Ranking # 2079 # 0 # 0 # 0 # 0
Seq. Revenue Change 22.4 % 12.85 % -4.28 % 14.65 % -43.25 %

XLRN Company Profile >> Back to XLRN Efficiency Comparisons >> Compare XLRN Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 45
Healthcare Sector # 210
Overall Market # 2079

Revenue per Employee Statistics
High Average Low
$ 250,971 $ 96,611 $ 28,907
(Mar 31 2021)   (Mar 31 2018)



Financial Statements
Acceleron Pharma Inc's Revenue MRQ $ 34 Millions Visit XLRN's Income Statement
Acceleron Pharma Inc's Revenues TTM $ 113 Millions Visit XLRN's aggregate revenue growth
What are XLRN's Sales? Visit XLRN's Sales by Segment




Other Ratios
Acceleron Pharma Inc's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
XLRN's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for XLRN's Competitors
Revenue per Employee for XLRN's Suppliers
Revenue per Employee for XLRN's Customers

You may also want to know
XLRN's Sales Growth Rates XLRN's Pe Price to earnings ratio XLRN's Receivables Turnover Ratio XLRN's Stock Quote
XLRN's Net Income Growth Rates XLRN's Ps Price to Sales ratio XLRN's Sales per Employee XLRN's Asset Turnover Ratio
XLRN's Net Margin XLRN's Pb Price to Book ratio XLRN's Financial Strength Ratios XLRN's Dividend Payout Ratio
Date modified: 2026-08-29T17:22:17+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2021, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2021Number of Employees Sep 30 2021
Sutro Biopharma Inc   434,335.77 $ 59.504  Million 137 
Fuse Medical Inc   419,008.49 $ 21.369  Million 51 
Resmed Inc   417,489.62 $ 4,746.857  Million 11,370 
Bausch Health Companies Inc   416,305.42 $ 8,451.000  Million 20,300 
Merus N v   413,466.67 $ 43.414  Million 105 
Heska Corporation  409,824.59 $ 249.993  Million 610 
Cumberland Pharmaceuticals Inc   407,814.15 $ 37.927  Million 93 
Nrc Health  404,565.83 $ 144.430  Million 357 
Orgenesis Inc   401,376.62 $ 30.906  Million 77 
Option Care Health Inc   401,180.62 $ 3,316.159  Million 8,266 
Elite Pharmaceuticals Inc   400,882.20 $ 26.057  Million 65 
Sqz Biotechnologies Company  400,813.95 $ 17.235  Million 43 
Bio rad Laboratories Inc   399,948.32 $ 2,979.615  Million 7,450 
Vtv Therapeutics Inc   399,807.69 $ 10.395  Million 26 
Macrogenics Inc   395,873.72 $ 115.991  Million 293 
Rockwell Medical inc   393,391.66 $ 61.762  Million 157 
Interpace Biosciences Inc   393,186.27 $ 40.105  Million 102 
Cardiff Lexington Corporation  392,157.17 $ 7.059  Million 18 
Aravive Inc   391,677.42 $ 12.142  Million 31 
Molecular Templates Inc   390,806.45 $ 24.230  Million 62 
10x Genomics Inc   389,794.57 $ 459.178  Million 1,178 
Vericel Corporation  386,487.44 $ 153.822  Million 398 
Cryo cell International Inc   383,027.16 $ 29.110  Million 76 
Nuvasive Inc  376,240.00 $ 1,128.720  Million 3,000 
Meridian Bioscience Inc   373,995.29 $ 317.896  Million 850 
Alimera Sciences Inc  370,088.05 $ 58.844  Million 159 
Immunogen inc   368,965.32 $ 127.662  Million 346 
Abbott Laboratories  367,895.65 $ 42,308.000  Million 115,000 
Amarin Corp Plcuk  367,240.61 $ 605.947  Million 1,650 
Xtant Medical Holdings Inc   366,278.15 $ 55.308  Million 151 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.